Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/16/2012US20120207779 Anaplasma phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma
08/16/2012US20120207778 Nucleic acids and proteins from streptococcus groups a and b
08/16/2012US20120207766 Intracellular toll-like receptors pathways and axonal degeneration
08/16/2012US20120207763 Pyrrolopyrimidine compounds and their uses
08/16/2012US20120207762 Stable pharmaceutical formulations
08/16/2012US20120207755 Cancer
08/16/2012US20120207751 Imidazoquinolines as lipid kinase inhibitors
08/16/2012US20120207744 Reprogramming compositions and methods of using the same
08/16/2012US20120207743 Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases
08/16/2012US20120207742 Treatments Using PSMA Ligand Endopeptidases
08/16/2012US20120207741 Enzymes For Pharmaceutical Use
08/16/2012US20120207740 Method for Treating Pervasive Development Disorders
08/16/2012US20120207739 Treatment of pre-term neonates
08/16/2012US20120207738 Pretreatment of Post Exposure Treatment for Exposure to a Toxic Substance by Pulmonary Delivery (Inhaler) of a Bioscavenger
08/16/2012US20120207737 Medical utility of glycan-binding proteins and glycans
08/16/2012US20120207736 Composition for cartilaginous tissue repair and a production method therefor
08/16/2012US20120207735 Non-cytotoxic protein conjugates
08/16/2012US20120207734 Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases
08/16/2012US20120207733 Treating a Disease of Hyperproliferation Using Retargeted Endopeptidases
08/16/2012US20120207732 Compositions and methods for promoting neuronal outgrowth
08/16/2012US20120207731 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
08/16/2012US20120207730 Methods and Compositions for Treating Viral Hemorrhagic Fever
08/16/2012US20120207729 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/16/2012US20120207726 Autism-associated biomarkers and uses thereof
08/16/2012US20120207721 Sorcs1 for the treatment of obesity
08/16/2012US20120207720 Laminins, derivatives, and compositions including same and methods for their therapeutic use
08/16/2012US20120207717 Methods for treating inhalation injury
08/16/2012US20120207709 Hbv antisense inhibitors
08/16/2012US20120207708 Biomarkers for cancer-related fatigue and use thereof
08/16/2012US20120207707 Methods and compositions for enhancing polypeptide production
08/16/2012US20120207706 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
08/16/2012US20120207705 Stem Cell Conditioned Medium Compositions
08/16/2012US20120207704 Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases
08/16/2012US20120207703 Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
08/16/2012US20120207690 Searching methods using genetic responsivity measurements
08/16/2012US20120207688 Rosacea Topical Skin Treatment Method and Formulation
08/16/2012US20120207680 Methods of Identifying Candidate Compounds of the Human G Protein-Coupled Receptor, GPR50, as Modulators of Body Mass or Adiposity
08/16/2012US20120207676 Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors
08/16/2012US20120207671 Combination treatment with vegf-c antagonists
08/16/2012CA2841404A1 Treatment of angiogenesis disorders
08/16/2012CA2827033A1 Lyophilized formulations
08/16/2012CA2827029A1 Peptide compositions and methods for treating patients
08/16/2012CA2826890A1 Compositions and methods for improving prognosis of a human with subarachnoid hemorrhage
08/16/2012CA2826853A1 Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
08/16/2012CA2826564A1 Treatment of osteoarthritis and pain
08/16/2012CA2825770A1 Immunogenic composition comprising alpha-hemolysin oligopeptides
08/16/2012CA2825118A1 Modified plant defensins useful as anti-pathogenic agents
08/16/2012CA2824746A1 Skin collagen production-promoting agent
08/16/2012CA2824578A1 Citrate free pharmaceutical compositions comprising anakinra
08/15/2012EP2487185A1 Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
08/15/2012EP2487184A1 Glucagon/GLP-1 receptor co-agonists
08/15/2012EP2486937A1 Methods for treating a urethral stricture with a botulinum toxin
08/15/2012EP2486936A1 A composition comprising VWF and FVIII preparations for use in treating of bleeding disorders
08/15/2012EP2486935A1 Epitopes related to Coeliac Disease
08/15/2012EP2486934A1 Epitopes Related To Coeliac Disease
08/15/2012EP2486933A1 Monomethylvaline compounds conjugated with antibodies
08/15/2012EP2486916A1 Human growth hormone formulations
08/15/2012EP2486134A1 Use of toll-like receptor and agonist for treating cancer
08/15/2012EP2486128A1 Use of pedf in an encapsulated cell-based delivery system
08/15/2012EP2486058A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same
08/15/2012EP2486051A1 Pharmaceutical preparation comprising recombinant hcg
08/15/2012EP2485759A2 Methods, agents and peptides for inducing an innate immune response in hiv vaccination
08/15/2012EP2485756A2 Glp-2 for use in intestine and muscle recovery
08/15/2012EP2485755A2 Delivery of bmp-7 and methods of use thereof
08/15/2012EP2485754A1 Methods and compositions for skin regeneration
08/15/2012EP2485753A1 Chaperonin 10 variants
08/15/2012EP2485752A2 Enterotoxigenic e. coli fusion protein vaccines
08/15/2012EP2485751A2 Methods of treating depression and other related diseases
08/15/2012EP2485750A1 Peptide-based peroxidase inhibitors and methods of using same
08/15/2012EP2485749A1 Methods for the prevention or treatment of heart failure
08/15/2012EP2485748A1 Method of treating cravings by administration of nerve growth factor
08/15/2012EP2485747A1 Dna-directed customization of analgesic compounds as a therapeutic modality
08/15/2012EP2485739A1 Methods and compositions for maintenance of a functional wound
08/15/2012EP2485725A2 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
08/15/2012EP2293808B1 An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
08/15/2012EP2219607B1 Liquid LH formulations
08/15/2012EP2212334B1 Proteasome inhibitors
08/15/2012EP2205268B1 Interferon alpha sequential regimen for treating cancers
08/15/2012EP2170930B1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
08/15/2012EP2167117B1 Use of vwf stabilized fviii preparations for extravascular administration in the therapy and prophylactic treatment of bleeding disorders
08/15/2012EP2153843B1 Compositions and methods for the diagnosis and treatment of tumor
08/15/2012EP2115134B1 citrullinated enolase peptides
08/15/2012EP2030628B1 A peptide for preventing or treating liver damage and its derivant and the use
08/15/2012EP1922081B1 Interferon lambda therapy for treatment of respiratory diseases
08/15/2012EP1894567B1 Concomitant pharmaceutical agents and use thereof
08/15/2012EP1751181B1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
08/15/2012EP1705182B1 Antitumoral and antiviral peptides
08/15/2012EP1648922B3 Spatially-defined macrocyclic compounds useful for drug discovery
08/15/2012EP1644406B1 Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
08/15/2012EP1594524B1 Use of tryptanthrin compounds for immune potentiation
08/15/2012EP1576170B1 Nucleic acids and corresponding proteins entitled 191p4d12(b) useful in treatment and detection of cancer
08/15/2012EP1576132B1 Nucleic acids entitled 273p4b7 and their use in detection of cancer
08/15/2012EP1515749B1 Combined use of a modulator of cd3 and a glp-1 compound
08/15/2012EP1420716B1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN102639556A Polypeptides and uses thereof
08/15/2012CN102639555A Bladder cancer specific ligand peptides
08/15/2012CN102639553A Method of purifying pegylated proteins
08/15/2012CN102639145A A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
08/15/2012CN102639144A Long-acting coagulation factors and methods of producing same
1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 3163